French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting unnamed sources.

The drugmaker, believed to working with Evercore Partners, is said to have contacted potential buyers.

The drugs for sale would include treatments for high blood pressure and cardio-metabolic diseases and have roughly $3.7 billion in combined annual revenue, a source told the news agency, adding that the portfolio could fetch up to two times that amount.

Generic drugmakers and specialty pharmaceutical companies are seen as logical buyers for the Sanofi drug portfolio.